Studies involving multiple aspects of plaque psoriasis evolution, persistence, and progression have produced clues and ...

Oral opioid use is common among patients with SPRA, ankylosing spondylitis, and PsA and is associated with an increased risk for mortality.

Substantial savings opportunities exist by using lower-cost biologics for patients with plaque psoriasis, according to one ...

Apremilast treatment in patients with psoriatic arthritis leads to favorable changes in body composition and improves disease ...

Johnson & Johnson (J&J) has shared positive results from a phase 3b study of Tremfya (guselkumab) in adults with psoriatic arthritis (PsA). The APEX trial has been comparing the drug against placebo ...

Icotrokinra had more significant improvements than placebo for multiple skin clearance measures following 16 weeks of treatment for plaque psoriasis in adolescents and adults. Icotrokinra is ...

The significance of diet in managing arthritis has been emphasised by experts, who have provided guidance on what to consume to alleviate pain and inflammation. The Mediterranean diet, renowned ...

Many people who have psoriasis will experience the telltale sign of itchiness or burning. But for people with differing skin tones, that’s where the similarities may end. The symptoms of ...

Among a large cohort of young adults with psoriatic arthritis, 38.8% exhibited radiographic evidence of degenerative disc disease. Researchers in Canada conducted a retrospective cohort study to ...

US-based pharmaceutical company Johnson & Johnson (J&J) has reported positive results from a Phase IIIb trial of its monoclonal antibody Tremfya (guselkumab) for active psoriatic arthritis (PsA).

Patients with psoriatic arthritis (PsA) experienced longer diagnostic delays than matched patients with rheumatoid arthritis (RA). Patients with polyarticular PsA received less intensive disease ...

Psoriatic arthritis represents a complex intersection of immune dysfunction where inflammation targets both skin and joints, creating a condition that challenges patients and clinicians alike.